Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with outcomes from the VISION trial. An analysis of outcomes from a French early-access program, the…
Swiss Cancer Institute Team Looks Forward to Discussions and Connections With the International Oncology Community at ESMO 2026 Oncodaily
How Is Targeted Therapy Changing Non–Small Cell Lung Cancer Treatment? Targeted Oncology
KC-WISE at ESMO 2026: Updated Overall Survival With Anbenitamab Plus Chemotherapy in HER2-Positive Gastric and GEJ Cancer Oncodaily
The addition of a personalized vaccine to standard adjuvant therapy reduced risk for recurrence or death by 42% among patients with completely resected high-risk melanoma, according to results of the randomized phase 3 INTerpath-001 trial. The combination also reduced risk for distant metastasis or death by 38%…
ASCO Issues Its First Living Guideline on Systemic Treatment of Recurrent Ovarian Cancer The ASCO Post
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study | Newswise Newswise
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study Mayo Clinic News Network
Повышение осведомленности о раке молочной железы: проактивная и улучшенная ранняя диагностика. Vietnam.vn
Atlantic Health gets record $5M gift for cancer research NJBIZ
FORTITUDE-101 and FORTITUDE-102 at ESMO 2026: Bemarituzumab Efficacy by FGFR2 Amplification Status in Gastric and GEJ Cancer Oncodaily
Personalized cancer vaccine cuts risk of melanoma recurrence or death by 42% in trial Anadolu Ajansı
Michelle Mitchell: CRUK Scotland Institute Celebrates 50 Years of Cancer Research and Innovation Oncodaily
An overlooked mechanism in lung cancer tumors may help explain why most patients don't respond to immunotherapy, according to new research led by Olga Anczuków, professor at The Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, and deputy director of the NCI-designated Jackson Laboratory Cancer…